AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

EIDOS THERAPEUTICS INVESTOR ALERT BY The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Eidos Therapeutics, Inc. - EIDX

October 9, 2020 GMT

NEW ORLEANS--(BUSINESS WIRE)--Oct 9, 2020--

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Eidos Therapeutics, Inc. (NasdaqGS: EIDX) to BridgeBio Pharma, Inc. (NasdaqGS: BBIO). Under the terms of the proposed transaction, shareholders of Eidos will receive either 1.85 shares of BridgeBio common stock or $73.26 in cash for each share of Eidos that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

ADVERTISEMENT

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( lewis.kahn@ksfcounsel.com ) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-eidx/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20201009005558/en/

CONTACT: Lewis S. Kahn

KSF Managing Partner

lewis.kahn@ksfcounsel.com

855-768-1857

KEYWORD: UNITED STATES NORTH AMERICA LOUISIANA

INDUSTRY KEYWORD: LEGAL PROFESSIONAL SERVICES

SOURCE: Kahn Swick & Foti, LLC

Copyright Business Wire 2020.

PUB: 10/09/2020 02:38 PM/DISC: 10/09/2020 02:37 PM

http://www.businesswire.com/news/home/20201009005558/en